Molecular Monitoring of RUNX1-RUNX1T1 Transcript Level in Acute Myeloblastic Leukemias on Treatment

Background. The current approach to treatment of acute myeloblastic leukemia (AML) includes the achievement of maximum tumor reduction and, therefore, eradication of a leukemic clone. The goal of the therapy is to achieve undetectable levels of the target gene, except an isolated molecular rearrange...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:Клиническая онкогематология
المؤلفون الرئيسيون: LL Girshova, EG Ovsyannikova, SO Kuzin, EN Goryunova, RI Vabishchevich, AV Petrov, DV Motorin, DV Babenetskaya, VV Ivanov, KV Bogdanov, IV Kholopova, TS Nikulina, YuV Mirolyubova, YuA Alekseeva, AYu Zaritskii
التنسيق: مقال
اللغة:الروسية
منشور في: Practical Medicine Publishing House 2016-10-01
الموضوعات:
acute myeloblastic leukemia
AML
RUNX1-RUNX1T1
molecular monitoring
الوصول للمادة أونلاين:http://bloodjournal.ru/en/molecular-monitoring-of-runx1-runx1t1-transcript-level-in-acute-myeloblastic-leukemias-on-treatment/

الانترنت

http://bloodjournal.ru/en/molecular-monitoring-of-runx1-runx1t1-transcript-level-in-acute-myeloblastic-leukemias-on-treatment/

مواد مشابهة